BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 29631371)

  • 1. Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.
    Mattapally S; Zhu W; Fast VG; Gao L; Worley C; Kannappan R; Borovjagin AV; Zhang J
    Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H327-H339. PubMed ID: 29631371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids.
    Tan Y; Richards D; Coyle RC; Yao J; Xu R; Gou W; Wang H; Menick DR; Tian B; Mei Y
    Acta Biomater; 2017 Mar; 51():495-504. PubMed ID: 28087483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 5. Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.
    Gao L; Gregorich ZR; Zhu W; Mattapally S; Oduk Y; Lou X; Kannappan R; Borovjagin AV; Walcott GP; Pollard AE; Fast VG; Hu X; Lloyd SG; Ge Y; Zhang J
    Circulation; 2018 Apr; 137(16):1712-1730. PubMed ID: 29233823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
    Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
    Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
    Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.
    Fan C; Tang Y; Zhao M; Lou X; Pretorius D; Menasche P; Zhu W; Zhang J
    J Mol Cell Cardiol; 2020 Apr; 141():1-10. PubMed ID: 32169551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
    Tachibana A; Santoso MR; Mahmoudi M; Shukla P; Wang L; Bennett M; Goldstone AB; Wang M; Fukushi M; Ebert AD; Woo YJ; Rulifson E; Yang PC
    Circ Res; 2017 Sep; 121(6):e22-e36. PubMed ID: 28743804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.
    Tabei R; Kawaguchi S; Kanazawa H; Tohyama S; Hirano A; Handa N; Hishikawa S; Teratani T; Kunita S; Fukuda J; Mugishima Y; Suzuki T; Nakajima K; Seki T; Kishino Y; Okada M; Yamazaki M; Okamoto K; Shimizu H; Kobayashi E; Tabata Y; Fujita J; Fukuda K
    J Heart Lung Transplant; 2019 Feb; 38(2):203-214. PubMed ID: 30691596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
    Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J
    Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
    Fan C; Fast VG; Tang Y; Zhao M; Turner JF; Krishnamurthy P; Rogers JM; Valarmathi MT; Yang J; Zhu W; Zhang J
    J Mol Cell Cardiol; 2019 Dec; 137():25-33. PubMed ID: 31629738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC; Hsieh ML; Lin CJ; Chang CMC; Huang CY; Puntney R; Wu Moy A; Ting CY; Herr Chan DZ; Nicholson MW; Lin PJ; Chen HC; Kim GC; Zhang J; Coonen J; Basu P; Simmons HA; Liu YW; Hacker TA; Kamp TJ; Hsieh PCH
    Circulation; 2023 Oct; 148(18):1395-1409. PubMed ID: 37732466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction.
    Jiang Y; Sun SJ; Zhen Z; Wei R; Zhang N; Liao SY; Tse HF
    Stem Cell Res Ther; 2021 Jan; 12(1):13. PubMed ID: 33413626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.
    Gao L; Kupfer ME; Jung JP; Yang L; Zhang P; Da Sie Y; Tran Q; Ajeti V; Freeman BT; Fast VG; Campagnola PJ; Ogle BM; Zhang J
    Circ Res; 2017 Apr; 120(8):1318-1325. PubMed ID: 28069694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.
    Tao Z; Loo S; Su L; Tan S; Tee G; Gan SU; Zhang J; Chen X; Ye L
    Cardiovasc Res; 2021 May; 117(6):1578-1591. PubMed ID: 32666104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.